<ѻý>GLP-1 Drugs Could Help People With Alcohol Use Disorderѻý> Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
<ѻý>FDA Rejects Full Approval of Liver Disease Drugѻý> Agency's decision on obeticholic acid in PBC follows negative advisory committee meeting Nov 12, 2024
<ѻý>Rifaximin Reduced Overt Hepatic Encephalopathy Recurrence Over Lactuloseѻý> Rifaximin also reduced mortality, but its high cost may be a barrier Nov 01, 2024
<ѻý>Algorithm May Be Able to Predict HCC Risk in Advanced Chronic Liver Diseaseѻý> Easy to apply, uses parameters commonly measured in outpatient and inpatient settings Oct 25, 2024
<ѻý>Rainfall and Mortality; Identifying Risk for Preeclampsiaѻý> Also in TTHealthWatch: HIV-positive kidney donors Oct 19, 2024 podcast
<ѻý>Novel Drug Effective Against MASH in Phase II Trialѻý> Fatty acid synthase inhibitor targets main drivers of liver injury Oct 14, 2024
<ѻý>GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Deathѻý> Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
<ѻý>Another Possible Treatment Option for Intermediate-Stage Liver Cancerѻý> Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS Sep 16, 2024
<ѻý>Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Saysѻý> Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis Sep 13, 2024
<ѻý>FDA Warning on Hot Flash Drugѻý> Clinicians should perform liver blood tests before and during Veozah treatment Sep 12, 2024
<ѻý>FDA Reviewers Skeptical of Ocaliva for Rare Bile Duct Diseaseѻý> Agency advisory panel to examine complicated efficacy data and liver safety concerns Sep 11, 2024
<ѻý>Women With HCC Less Likely to Receive Liver Transplant, More Likely to Die Than Menѻý> This difference is mostly explained by their smaller stature, researchers say Sep 05, 2024
<ѻý>Rate of Mortality After ED Discharge for Cirrhosis Doubles That of Heart Failureѻý> Patients who lacked a follow-up visit may be at particularly high risk for death Aug 28, 2024
<ѻý>Amino Acids May Protect Kidneys During Surgery; EDTA for Chelation Therapyѻý> Also in TTHealthWatch: suicidality among spouses of people with cancer Aug 24, 2024 podcast
<ѻý>No Effect of Tranexamic Acid on Bleeding in Surgery for Liver Cancerѻý> No difference from placebo in transfusion rate, blood loss, with higher complication rate Aug 19, 2024
<ѻý>FDA OKs New Option for Primary Biliary Cholangitisѻý> Seladelpar improved biochemical response, ALP normalization versus placebo in phase III trial Aug 14, 2024
<ѻý>Millions of Americans Use Potentially Hepatotoxic Botanical Productsѻý> And liver injuries tied to herbal and dietary supplements are on the rise, data show Aug 05, 2024
<ѻý>Which Anticoagulant Is Safest for Afib Patients With Cirrhosis?ѻý> National cohort study finds up to 47% fewer serious hemorrhagic events with one agent Jul 08, 2024
<ѻý>Aspirin Overuse; Biotypes of Depression and Anxietyѻý> Also in TTHealthWatch: medications and the liver, and managing gestational diabetes Jun 30, 2024 podcast
<ѻý>FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adultsѻý> Results as quick as 1 hour, enabling a test-and-treat approach Jun 27, 2024
<ѻý>Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injuryѻý> Case reports may not be as reliable, researchers say Jun 25, 2024
<ѻý>Novel GLP-1/Glucagon Drug Promising for Weight Lossѻý> Phase II data support testing pemvidutide for comorbid obesity and liver conditions Jun 24, 2024
<ѻý>Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancerѻý> No difference in PFS, median OS favored control group Jun 12, 2024
<ѻý>Testosterone Prodrug Improves Muscle Mass, Encephalopathy in Men With Cirrhosisѻý> Androgen precursor may help cirrhosis-related sarcopenia Jun 11, 2024
<ѻý>Rifaximin Prophylaxis Fails for Bacterial Peritonitis in Cirrhotic Patientsѻý> "Is it time to say primary prophylaxis is dead?" one expert asks Jun 11, 2024
<ѻý>Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approvalѻý> First-in-class PPAR agonist led to biochemical responses in more than 50% of patients in trial Jun 11, 2024
<ѻý>Patients With Severe ACLF on Liver Transplant Waitlists Face High Mortality Ratesѻý> Urgent need for organ allocation system reform, researchers say Jun 09, 2024
<ѻý>Weight Loss/Diabetes Drug Has Positive Treatment Effect on MASHѻý> GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial Jun 08, 2024
<ѻý>Novel Glucagon/GLP-1 Receptor Dual Agonist Improved MASH in Phase II Studyѻý> Effects may be related to weight loss, not changes in fibrogenesis, expert suggests Jun 07, 2024
<ѻý>Novel Intelligent Liver Function Test Platform Improves Liver Disease Diagnosisѻý> iLFT is now an essential, highly utilized tool at one U.K. primary care system Jun 07, 2024
<ѻý>Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis Dѻý> Combo therapies for HDV with drugs other than pegylated interferon would be better, expert says Jun 06, 2024
<ѻý>Changes to Liver Transplant Policy Increased Costs in Vulnerable Areasѻý> Hospital costs increased 12% in low-income areas vs 5.1% in high-income areas May 29, 2024
<ѻý>FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancerѻý> Sponsor for infigratinib (Truseltiq) failed to recruit and enroll patients in confirmatory study May 20, 2024
<ѻý>Resection for Early Liver Cancer Tied to Improved Survivalѻý> 5-year OS rate nearly doubled vs nonsurgical approaches for early HCC, retrospective study finds May 15, 2024
<ѻý>Liver Disease, High Lipoprotein(a) Tied to Higher MI Risk in Diabetes Patientsѻý> Sixfold increased risk of non-fatal MI among patients with highest levels of Lp(a) May 13, 2024
<ѻý>Are Health Workers More Prone to Alcohol-Related Death?ѻý> No, and physicians appear to have the lowest risk May 08, 2024
<ѻý>Rare Pregnancy Problem Linked to Thiopurines, FDA Saysѻý> Agency finds risk for intrahepatic cholestasis of pregnancy mostly in IBD, lupus patients May 03, 2024
<ѻý>Liver Cancer Screening Benefits Patients With Cirrhosis, Study Suggestsѻý> Analysis still finds improved survival after correcting for lead- and length-time biases May 01, 2024
<ѻý>EPA Bans Consumer Use of Toxic Chemical Known to Cause Liver, Lung Cancersѻý> Methylene chloride has killed at least 88 workers since 1980 Apr 30, 2024